National Cancer Institute
Grant Status Active
Division Division of Cancer Control and Population Sciences
Program Epidemiology and Genomics Research Program (EGRP)
Topic Pharmacogenomics and Pharmacoepidemiology
Grant Listing (Instructions)
First Prev Next Last Separator Separator XLS
21 results found, displaying 1 to 21 Arrow Filter Clear
PI Name Organization Name Project Title
(Click for Abstract, Pubs, etc.)
Grant Number Awarded Dollars Fiscal Year
Ambrosone, Christine B. Roswell Park Cancer Institute Corp Genome-Wide Predictors of Treatment-Related Toxicities 5R01CA139426-03 $927,470 2013
Aplenc, Richard Children's Hosp of Philadelphia Genetic Predictors of Aml Treatment Response 5R01CA133881-04 $522,609 2013
Armenian, Saro Beckman Research Institute/City of Hope Anthraycline-Related Cardiotoxicity in Long-Term Survivors of Lymphoma 1R21CA178344-01 $189,963 2013
Bernatsky, Sasha Ruth Mcgill University Health Ctr Res Inst Cancer Risk: Advancing Knowledge in Systemic Rheumatic Disease 1R03CA173822-01A1 $70,167 2013
Bhatia, Smita Beckman Research Institute/City of Hope Role of Genetic Susceptibility in Therapy-Related Subsequent Malignancies 5R01CA139633-04 $569,900 2013
Boudreau, Denise M Group Health Cooperative Metformin and Breast Cancer Risk 1R03CA167589-01A1 $80,000 2013
Chubak, Jessica Group Health Cooperative Commonly Used Medications and Risk of Colorectal Cancer Recurrence 1R01CA172073-01A1 $600,838 2013
Fuchs, Charles S Dana-Farber Cancer Inst Impact of Celecoxib and Inflammation on Survival in Stage Iii Colon Cancer 1R01CA169141-01A1 $633,285 2013
Habel, Laurel A Kaiser Foundation Research Institute Pharmaceuticals and Cancer 5R01CA098838-10 $399,257 2013
Johnson, Christine C Henry Ford Health System Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort 5R01CA140754-04 $523,362 2013
Kushi, Lawrence H Kaiser Foundation Research Institute Prospective Study of Breast Cancer Survivorship 5R01CA105274-10 $1,880,992 2013
Lash, Timothy L Emory University New and Integrated Perspectives on Modification of Tamoxifen Effectiveness 1R01CA166825-01A1 $579,942 2013
Lerman, Caryn University of Pennsylvania Pharmacogenetics of Nicotine Addiction Treatment 5U01DA020830-09 $569,799 2013
Luke, Barbara Joan Michigan State University Assisted Reproductive Technology & Risk of Childhood Cancer 5R01CA151973-03 $569,243 2013
Malek, Sami Nimer University of Michigan Genomic Complexity and Clinical Outcome in Chronic Lymphocytic Leukemia 5R01CA136537-05 $291,182 2013
Motsinger-Reif, Alison North Carolina State University Raleigh Genetic Etiology of Cancer Drug Response 5R01CA161608-02 $446,811 2013
Relling, Mary V. St. Jude Children's Research Hospital Paar4kids-Pharmacogenomics of Anticancer Agents Research in Children 5U01GM092666-04 $90,960 2013
Wang, Rong Yale University Comparative Effectiveness of Treatments for Acute Myeloid Leukemia in the Elderly 1R03CA173810-01A1 $83,250 2013
Weinmann, Sheila A Kaiser Foundation Research Institute Cyp2d6 Gene Variants and Effectiveness of Adjuvant Tamoxifen in Breast Cancer 5R01CA155307-03 $534,276 2013
Weinshilboum, Richard M. Mayo Clinic Rochester Pharmacogenetics of Phase II Drug Metabolizing Enzymes 5U19GM061388-14 $682,202 2013
Wiencke, John K. University of California, San Francisco Biomarkers of Survival in Glioma Epidemiology 5R01CA126831-06 $253,843 2013